Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2021 - 04 - 20 save search
Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress
Published: 2021-04-20 (Crawled : 23:00) - globenewswire.com
AKTX | $1.25 3.31% 2.3K
|
Health Technology
|
| O: -0.42%
H: 5.02%
C: 0.0%
financial results results
SEC Filing: Form 10-K/A
Published: 2021-04-20 (Crawled : 21:00) - vynetherapeutics.com
VYNE | $2.335 0.65% 330K
|
Health Technology
|
| O: -0.78%
H: 0.0%
C: -5.31%
Associate Director/Director, Clinical Data Management
Published: 2021-04-20 (Crawled : 21:00) - nurixtx.com
NRIX 6 d | $13.65 -3.4% 190K
|
Health Technology
|
| O: -0.78%
H: 10.67%
C: 10.26%
Halozyme To Host First Quarter 2021 Financial Results Webcast And Conference Call
Published: 2021-04-20 (Crawled : 20:00) - halozyme.com
HALO M | $39.43 1.18% 210K
|
Health Technology
|
| O: -0.26%
H: 4.84%
C: 4.56%
financial results results conference
Y-mAbs Provides Regulatory Update on Omburtamab
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
YMAB | $15.145 -1.27% 55K
|
Health Technology
|
| O: -1.06%
H: 4.37%
C: 3.69%
Medical Writer
Published: 2021-04-20 (Crawled : 16:00) - nurixtx.com
NRIX 6 d | $13.65 -3.4% 190K
|
Health Technology
|
| O: -1.23%
H: 4.73%
C: 2.11%
CORRECTING AND REPLACING -- Agile Therapeutics
Published: 2021-04-20 (Crawled : 15:00) - globenewswire.com
AGRX | $0.37 95K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -1.68%
therapeutics
Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing
Published: 2021-04-20 (Crawled : 14:15) - globenewswire.com
BEAM | $22.88 -2.51% 290K
|
Health Technology
|
| O: -0.76%
H: 4.21%
C: 1.01%
designation
Hoth Therapeutics Announces its mRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth in Mast Cell-Derived Cancers
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
HOTH | $1.19 3.3K
|
Health Technology
|
| O: 23.29%
H: 7.22%
C: -14.44%
cancer growth
Sorrento Announces Positive Results of Phase 1b Study of COVI-MSC™ Treatment of ICU Covid-19 Patients, Achieving 100% (10 out 10) Discharge Rate
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
SRNE | $0.015 56K
|
Health Technology
|
| O: 0.8%
H: 1.85%
C: -1.72%
covid treatment positive results phase 1 positive results phase 1b phase 2b
Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of Directors
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
FDMT M | $24.735 -0.3% 90K
|
Health Technology
|
| O: -0.33%
H: 0.64%
C: -2.92%
MRVI 4 | $7.73 0.13% 600K
|
Commercial Services
|
| O: 0.08%
H: 1.33%
C: -3.32%
ZYME | $8.59 0.35% 59K
|
Health Technology
|
| O: -0.98%
H: 0.66%
C: -2.65%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.08%
H: 0.42%
C: 0.42%
NSIT | $184.1 -1.17% 55K
|
Technology Services
|
| O: 0.24%
H: 0.0%
C: -1.84%
ILMN | $121.3 -2.54% 310K
|
Health Technology
|
| O: -0.58%
H: 1.27%
C: -0.86%
ATEC | $12.625 -2.36% 420K
|
Health Technology
|
| O: -0.55%
H: 0.56%
C: -1.36%
biotech iot
Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020Live Conference Call and Webcast at 4:30 p.m. EDT
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
AGRX | $0.37 95K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -1.68%
financial results results conference
Cyclo Therapeutics to Proceed with IND Filing for Phase 2 Trial Using Intravenous Trappsol® Cyclo™ in Alzheimer’s Disease
Published: 2021-04-20 (Crawled : 14:00) - biospace.com/
CYTH | $1.21 9.3K
|
Professional, Scientific, and T...
|
| O: 5.04%
H: 3.01%
C: 1.57%
disease alzheimer phase 2 trial alzheimer’s alzheimer's disease alzheimer's
Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020
Published: 2021-04-20 (Crawled : 14:00) - globenewswire.com
AGRX | $0.37 95K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -1.68%
financial results results
LUNGevity Launches Campaign Focused on Increasing Lung Cancer Survival by Driving Awareness of Comprehensive Biomarker Testing
Published: 2021-04-20 (Crawled : 13:15) - prnewswire.com
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: -0.08%
H: 0.42%
C: 0.42%
NEO | $13.92 -1.7% 180K
|
Health Services
|
| O: -0.58%
H: 2.35%
C: 0.04%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -0.66%
H: 1.94%
C: 1.23%
lung cancer test cancer biomarkers
Immunomic Therapeutics Announces License Agreement With Lineage Cell Therapeutics for Cancer Immunotherapy
Published: 2021-04-20 (Crawled : 13:00) - biospace.com/
LCTX | $1.115 -2.19% 370K
|
Health Technology
|
| O: 7.34%
H: 2.99%
C: -2.56%
immunotherapy therapy cancer license therapeutics
Lineage Announces Worldwide License Agreement With Immunomic Therapeutics for an Allogeneic Cell-Based Cancer Immunotherapy Based on Its VAC Platform
Published: 2021-04-20 (Crawled : 13:00) - biospace.com/
LCTX | $1.115 -2.19% 370K
|
Health Technology
|
| O: 7.34%
H: 2.99%
C: -2.56%
immunotherapy therapy cancer license
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021 Financial Results
Published: 2021-04-20 (Crawled : 12:15) - prnewswire.com
PTCT | News S | $25.24 -0.67% 180K
|
Health Technology
|
| O: -0.82%
H: 2.59%
C: -1.78%
financial results results conference
Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals
Published: 2021-04-20 (Crawled : 12:15) - globenewswire.com
ZNTL | $12.06 -4.06% 140K
|
Health Technology
|
| O: -0.43%
H: 3.3%
C: 0.59%
collaboration drug discovery drug
Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board
Published: 2021-04-20 (Crawled : 12:00) - investors.ovidrx.com
OVID | $3.115 -2.66% 25K
|
Health Technology
|
| O: -2.97%
H: 1.95%
C: 0.28%
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $1.88 60.68% 98M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.